Early Upregulation of Matrix Metalloproteinases Following Reperfusion Triggers Neuroinflammatory Mediators in Brain Ischemia in Rat

Akita, 1997, Involvement of caspase‐1 and caspase‐3 in the production and processing of mature human interleukin 18 in monocytic THP.1 cells, J. Biol. Chem., 272, 26595, 10.1074/jbc.272.42.26595 Asahi, 2000, Role for matrix metalloproteinase 9 after focal cerebral ischemia: Effects of gene knockdown and enzyme inhibition with BB‐94, J. Cereb. Blood Flow Metab., 20, 1681, 10.1097/00004647-200012000-00007 Asahi, 1997, Expression of interleukin‐1 beta converting enzyme gene family and bcl‐2 gene family in the rat brain following permanent occlusion of the middle cerebral artery, J. Cereb. Blood Flow Metab., 17, 11, 10.1097/00004647-199701000-00003 Asahi, 2001, Matrix metalloproteinase 2 gene knockout has no effect on acute brain injury after focal ischemia, Neuroreport, 12, 3003, 10.1097/00001756-200109170-00050 Asahi, 2001, Effects of matrix metalloproteinase‐9 gene knock‐out on the proteolysis of blood‐brain barrier and white matter components after cerebral ischemia, J. Neurosci., 21, 7724, 10.1523/JNEUROSCI.21-19-07724.2001 Benchoua, 2001, Specific caspase pathways are activated in the two stages of cerebral infarction, J. Neurosci., 21, 7127, 10.1523/JNEUROSCI.21-18-07127.2001 Black, 1988, Generation of biologically active interleukin‐1β by proteolytic cleavage of the inactive precursor, J. Biol. Chem., 263, 9437, 10.1016/S0021-9258(19)76559-4 Brooks, 1996, Localization of matrix metalloproteinase MMP‐2 to the surface of invasive cells by interaction with integrin alpha v beta 3, Cell, 85, 683, 10.1016/S0092-8674(00)81235-0 Buttini, 1994, Induction of interleukin‐1beta mRNA after focal ischemia in the rat, Mol. Brain Res., 23, 126, 10.1016/0169-328X(94)90218-6 Castellanos, 2003, Plasma metalloproteinase‐9 concentration predicts hemorrhagic transformation in acute ischemic stroke, Stroke, 34, 40, 10.1161/01.STR.0000046764.57344.31 Chen, 2003, The hippocampal laminin matrix is dynamic and critical for neuronal survival, Mol. Biol. Cell, 14, 2665, 10.1091/mbc.E02-12-0832 Copin, 2005, Role of matrix metalloproteinases in apoptosis after transient focal cerebral ischemia in rats and mice, Eur. J. Neurosci., 22, 1597, 10.1111/j.1460-9568.2005.04367.x Corasaniti, 2001, Evidence that increases of mitochondrial immunoreactive IL‐1β by HIV‐1 gp120 implicate in situ cleavage of pro‐IL‐1β in the neocortex of rat, J. Neurochem., 78, 611, 10.1046/j.1471-4159.2001.00441.x Corasaniti, 2005, Neuroprotection by the caspase‐1 inhibitor Ac‐YVAD‐(acyloxy)mk in experimental neuroAIDS is independent from IL‐1β generation, Cell Death Differ., 12, 999, 10.1038/sj.cdd.4401644 Cunningham, 2005, Multiple roles for MMPs and TIMPs in cerebral ischemia, Glia, 50, 329, 10.1002/glia.20169 Davies, 1999, The progression and topographic distribution of interleukin‐1 beta expression after permanent middle cerebral artery occlusion in the rat, J. Cereb. Blood Flow Metab., 19, 87, 10.1097/00004647-199901000-00010 Dubois, 1998, Regulation of gelatinase B (MMP‐9) in leukocytes by plant lectins, FEBS Lett., 427, 275, 10.1016/S0014-5793(98)00449-9 Eriksson, 1999, Immunohistochemical localization of interleukin‐1β, interleukin‐1 receptor antagonist and interleukin‐1β converting enzyme/caspase‐1 in the rat brain after peripheral administration of kainic acid, Neuroscience, 93, 915, 10.1016/S0306-4522(99)00178-5 Fantuzzi, 1997, Response to local inflammation of IL‐1β‐converting enzyme‐deficient mice, J. Immunol., 158, 1818, 10.4049/jimmunol.158.4.1818 Friedlander, 1998, ICE, neuronal apoptosis and neurodegeneration, Cell Death Differ., 5, 823, 10.1038/sj.cdd.4400433 Garcia, 1995, Interleukin‐1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion, Am. J. Pathol., 147, 1477 Garcia‐Calvo, 1998, Inhibition of human caspases by peptide‐based and macromolecular inhibitors, J. Biol. Chem., 273, 32608, 10.1074/jbc.273.49.32608 Gasche, 2001, Matrix metalloproteinase inhibition prevents oxidative stress associated blood‐brain barrier disruption after transient focal cerebral ischemia, J. Cereb. Blood Flow Metab., 21, 1393, 10.1097/00004647-200112000-00003 Goldberg, 1992, Interaction of 92‐kDa type IV collagenase with the tissue inhibitor of metalloproteases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin, J. Biol. Chem., 267, 4583, 10.1016/S0021-9258(18)42873-6 Gu, 2002, S‐nitrosylation of matrix metalloproteinases: Signalling pathway to neuronal cell death, Science, 297, 1186, 10.1126/science.1073634 Gu, 2005, A highly specific inhibitor of matrix metalloproteinase‐9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia, J. Neurosci., 25, 6401, 10.1523/JNEUROSCI.1563-05.2005 Hagan, 1996, Intracerebral NMDA injection stimulates production of interleukin‐1β in perinatal rat brain, J. Neurochem., 67, 2215, 10.1046/j.1471-4159.1996.67052215.x Hara, 1997, Attenuation of transient focal cerebral ischemic injury in transgenic mice expressing a mutant ICE inhibitory protein, J. Cereb. Blood Flow Metab., 17, 370, 10.1097/00004647-199704000-00002 Hara, 1997, Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage, Proc. Natl. Acad. Sci. USA, 94, 2007, 10.1073/pnas.94.5.2007 Heo, 1999, Matrix metalloproteinases increase very early during experimental focal cerebral ischemia, J. Cereb. Blood Flow Metab., 19, 624, 10.1097/00004647-199906000-00005 Horstmann, 2003, Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: Influence of different therapies, Stroke, 34, 2165, 10.1161/01.STR.0000088062.86084.F2 Howard, 1991, IL‐1‐converting enzyme requires aspartic acid residues for processing of the IL‐1β precursor at two distinct sites and does not cleave 31‐kDa IL‐1α, J. Immunol., 147, 2964, 10.4049/jimmunol.147.9.2964 Ito, 1996, Degradation of interleukin 1β by matrix metalloproteinases, J. Biol. Chem., 271, 14657, 10.1074/jbc.271.25.14657 Jourquin, 2003, Neuronal activity‐dependent increase of net matrix metalloproteinase activity is associated with MMP‐9 neurotoxicity after kainate, Eur. J. Neurosci., 18, 1507, 10.1046/j.1460-9568.2003.02876.x Lee, 2001, Regulation of cell survival by secreted proneurotrophins, Science, 294, 1945, 10.1126/science.1065057 Legos, 2000, Quantitative changes in interleukin proteins following focal stroke in the rat, Neurosci. Lett., 282, 189, 10.1016/S0304-3940(00)00907-1 Levy, 1998, Matrix metalloproteinase inhibitors: A structure‐activity study, J. Med. Chem., 41, 199, 10.1021/jm970494j Li, 2000, Caspase inhibitors reduce neuronal injury after focal but not global cerebral ischemia in rats, Stroke, 31, 176, 10.1161/01.STR.31.1.176 Liu, 1993, Interleukin‐1‐beta messenger RNA expression in ischemic rat cortex, Stroke, 24, 1746, 10.1161/01.STR.24.11.1746 Longa, 1989, Reversible middle cerebral artery occlusion without craniotomy in rats, Stroke, 20, 84, 10.1161/01.STR.20.1.84 Magnoni, 2004, Differential alterations in the expression and activity of matrix metalloproteinases 2 and 9 after transient cerebral ischemia in mice, Neurobiol. Dis., 17, 188, 10.1016/j.nbd.2004.07.020 Mulcahy, 2003, Delayed administration of interleukin‐1 receptor antagonist protects against transient cerebral ischemia in the rat, Br. J. Pharmacol., 140, 471, 10.1038/sj.bjp.0705462 O'Shea, 2005, 3,4‐methylenedioxymethamphetamine increases prointerleukin‐1β production and caspase‐1 protease activity in frontal cortex, but not in hypothalamus, of Dark Agouti rats: Role of inteleukin‐1β in neurotoxicity, Neuroscience, 135, 1095, 10.1016/j.neuroscience.2005.06.084 Pagenstecher, 2000, Regulation of matrix metalloproteinases and their inhibitor genes in lipopolysaccaride‐induced endotoxemia in mice, Am. J. Pathol., 157, 197, 10.1016/S0002-9440(10)64531-2 Parks, 2004, Matrix metalloproteinases as modulators of inflammation and innate immunity, Nat. Rev. Immunol., 4, 617, 10.1038/nri1418 Planas, 2001, Expression and activation of matrix metalloproteinase‐2 and ‐9 in rat brain after transient focal cerebral ischemia, Neurobiol. Dis., 8, 834, 10.1006/nbdi.2001.0435 Rabuffetti, 2000, Inhibition of caspase‐1‐like activity by Ac‐Tyr‐Val‐Ala‐Asp‐Chloromethyl ketone induces long‐lasting neuroprotection in cerebral ischemia through apoptosis reduction and decrease of proinflammatory cytokines, J. Neurosci., 20, 4398, 10.1523/JNEUROSCI.20-12-04398.2000 Rano, 1997, A combinatorial approach for determining protease specificities: Application to interleukin‐1beta converting enzyme (ICE), Chem. Biol., 4, 149, 10.1016/S1074-5521(97)90258-1 Relton, 1992, Interleukin‐1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat, Brain Res. Bull., 29, 242, 10.1016/0361-9230(92)90033-T Relton, 1996, Peripheral administration of interleukin‐1 receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat, Exp. Neurol., 138, 206, 10.1006/exnr.1996.0059 Rivera, 2002, Gelatinase B and TIMP‐1 are regulated in a cell‐ and time‐dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia, Eur. J. Neurosci., 15, 19, 10.1046/j.0953-816x.2001.01838.x Romanic, 1998, Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: Inhibition of matrix metalloproteinase‐9 reduces infarct size, Stroke, 29, 1020, 10.1161/01.STR.29.5.1020 Rosell, 2006, Increased brain expression of matrix metalloproteinase‐9 after ischemic and hemorrhagic human stroke, Stroke, 37, 1399, 10.1161/01.STR.0000223001.06264.af Rosenberg, 2002, Matrix metalloproteinases in neuroinflammation, Glia, 39, 279, 10.1002/glia.10108 Rosenberg, 1996, Proteolytic cascade enzymes increase in focal cerebral ischemia in rat, J. Cereb. Blood Flow Metab., 16, 360, 10.1097/00004647-199605000-00002 Rosenberg, 1998, Matrix metalloproteinases and TIMPs are associated with blood‐brain barrier opening after reperfusion in rat brain, Stroke, 29, 2189, 10.1161/01.STR.29.10.2189 Rosenberg, 2001, Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: Activation of MMP‐9 linked to stromelysin‐1 and microglia in cell cultures, Brain Res., 893, 104, 10.1016/S0006-8993(00)03294-7 Rothwell, 2003, Interleukin‐1 and neuronal injury: Mechanisms, modification, and therapeutic potential, Brain Behav. Immun., 17, 152, 10.1016/S0889-1591(02)00098-3 Schielke, 1998, Reduced ischemic brain injury in interleukin‐1β converting enzyme‐deficient mice, J. Cereb. Blood Flow Metab., 18, 180, 10.1097/00004647-199802000-00009 Schönbeck, 1998, Generation of biologically active IL‐1β by matrix metalloproteinases: A novel caspase‐1‐independent pathway of IL‐1β processing, J. Immunol., 161, 3340, 10.4049/jimmunol.161.7.3340 Sternlicht, 2001, How matrix metalloproteinases regulate cell behaviour, Annu. Rev. Cell Dev. Biol., 17, 463, 10.1146/annurev.cellbio.17.1.463 Tewari, 1995, Yama/CPP32 beta, a mammalian homolg of CED‐3, is a CrmA‐inhibitable protease that cleaves the death substrate poly(ADP‐ribose) polymerase, Cell, 81, 801, 10.1016/0092-8674(95)90541-3 Thornberry, 1992, A novel heterodimeric cysteine protease is required for interleukin‐1β processing in monocytes, Nature, 356, 768, 10.1038/356768a0 Wang, 1994, Concomitant cortical expression of TNF‐α and IL‐1β mRNAs follows early response gene expression in transient focal ischemia, Mol. Chem. Neuropathol., 23, 103, 10.1007/BF02815404 Wetzel, 2003, Tissue inhibitor of metalloproteinase‐3 and matrix metalloproteinase‐3 regulate neuronal sensitivity to doxorubicin‐induced apoptosis, Eur. J. Neurosci., 18, 1050, 10.1046/j.1460-9568.2003.02838.x Yamasaki, 1995, Interleukin‐1 as a pathogenetic mediator of ischemic brain damage in the rats, Stroke, 26, 676, 10.1161/01.STR.26.4.676 Yang, 1999, Expression of tumor necrosis factor‐alpha and intercellular adhesion molecule‐1 after focal cerebral ischemia in interleukin‐1β converting enzyme deficient mice, J. Cereb. Blood Flow Metab., 19, 1109, 10.1097/00004647-199910000-00007 Yong, 2005, Metalloproteinases: Mediators of pathology and regeneration in the CNS, Nat. Rev. Neurosci., 6, 931, 10.1038/nrn1807 Zhang, 1998, Cerebral vessels express interleukin 1 beta after focal cerebral ischemia, Brain Res., 784, 210, 10.1016/S0006-8993(97)01317-6 Zhang, 2003, HIV‐induced metalloproteinase processing of the chemokine stromal cell derived factor‐1 causes neurodegeneration, Nat. Neurosci., 6, 1064, 10.1038/nn1127 Zhang, 2003, Fundamental role of the Rip2/caspase‐1 pathway in hypoxia and ischemia‐induced neuronal cell death, Proc. Natl. Acad. Sci. USA, 100, 16012, 10.1073/pnas.2534856100 Zhao, 2006, Role of matrix metalloproteinases in delayed cortical responses after stroke, Nat. Med., 12, 441, 10.1038/nm1387